Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma

Surgery Today

Volumn 27, Issue 8, 1997, Pages 719-725

  Würl, Peter ^a   Eichfeld, Uwe ^a   Pauer, Hans Dieter ^a   Gläser, Albrecht ^a   Rose, Uwe ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Arm perfusion; Melanoma; Melphalan; Recurrence; Survival

Indexed keywords

MELPHALAN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOREARM BLOOD FLOW; HUMAN; HYPERTHERMIC THERAPY; MELANOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ARM; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 0030877617     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02384984     Document Type: Article

References (40)

1. Eichfeld U, Gläser A, Schneider G, Kraus J, Pauer HJ, Schwarz I (1993) Die regionale zytostatische Extremitätenperfusion bei Patienten mit malignem Melanom und Weichteilsarkom - therapeutische Anwen-dungen und Ergebnisse. Zentralbl Chir 118:63-68
2. Hohenherger W, Meyer T, Göhl J (1994) Extremitätenperfusion heim malignen Melanom. Chirurg 65:175-185
3. Kettelhack C, Kraus T, Hupp T, Manner M, Schlag P (1990) Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol 16:370-375
4. Hafstrom L, Rudenstam CM, Blomquist E, Ingvar C, Jonsson PE, Lagerlof B, Lindholm C, Ringborg U, Westman G, Ostrup L (1991) Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. J Clin Oncol 9:2091-2094
5. Ghussen F, Krüger I, Groth W, Stützer H (1988) The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 61:654-659
6. Krementz ET, Carter RD, Sutherland CM, Campbell M (1979) The use of regional chemotherapy in the management of malignant melanoma. World J Surg 3:289-294
7. Krementz ET, Ryan RF, Muchmore JH, Carter RD (1992) Hyperthermic regional perfusion for melanoma of the limbs. In: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma. Lippincott, Philadelphia, pp 403-421
8. Creech O Jr, Kremenz ET, Ryan RF, Winhlad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporal circuit. Ann Surg 148:616-632
9. Cavalière R, Ciogatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Moricca G, Rossi-Fanelli A (1967) Selective heat sensitivity of cancer cells: Biochemical and clinical studies. Cancer 20:1351-1381
10. Oleson JR, Calderwood SK, Couglin CT, Dewhirst MW, Gerweck LE, Gibbs FA, Kapp DS (1988) Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 11:368-380
11. Pace M, Filomena A, Galli A (1991) Thermal induction and temperature control in the hyperthermic antiblastic regional perfusion with extracorporeal circulation. Adv Exp Med Biol 267:399-406
12. Strom R, Crifo C, Rossi-Fanelli A (1977) Biochemical aspects of heat sensivity of tumour cells. In: Selective heat sensitivity of cancer cells. Recent Results Cancer Res 59:229-241
13. Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140:339-348
14. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10:52-58
15. Sigurdsson GH, Nachbur B, Lejeune FJ (1993) Anesthesiologist's management of isolated limb perfusion with "high-dose" tumor necrosis factor alpha. Anesthesiology 79:1433-1437
16. Lienard D, Lejeune FJ, Ewalenko P (1992) In transit metastases of malignant melanoma treated by high dosr rTNF alpha in combination with interferon gamma and melphalan in isolation perfusion. World J Surg 16:234-240
17. Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N, Cascinelli N (1994) Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma interferon. and melphalan. Cancer 73:483-492
18. Kroon BBR (1988) Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. Eur J Surg Oncol 14:101-106
19. Rauschecker HF, Foth H, Michaelis HC, Horst F, Gatzemeier W, Willenbrock D, Voth E, Kahl GF (1991) Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb. Cancer Chemother Pharmacol 27:379-384
20. Thompson JF, Gianoutsos MP (1992) Isolated limbs perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J Surg 16:227-233
21. Hoeckstra HJ, Schraffordt Koops H, de Vries LGE, van Weerden TW, Oldhoff J (1993) Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer 72:1224-1229
22. Lejeune FJ, Lienard D, El Douahy M, Seyedi JV, Ewalenko P (1989) Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol 15:510-519
23. Hohenberger W (1990) Isolation perfusion for malignant melanomas: established facts and parameters to be clarrified. In: Jakesz R, Rainer H (eds) Progress in regional cancer therapy. Springer, Berlin Heidelberg New York, pp 182-197
24. Krementz ET (1987) Regional perfusion for melanoma of the limbs: prospects for cooperative studies in North America. In: Veronesi U, Cascinelli N, Santinami M (eds) Cutaneous melanoma. Status of knowledge and future perspetive. Academic. London, pp 589-611
25. Schraffordt Koops H, Kroon BB, Oldhoff J, Hoekstra HJ (1992) Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of extremities. World J Surg: 16:241-245
26. Mastrangelo MJ, Baker AR, Katz HR (1985) Cutaneous melanoma. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 1124-1170
27. Chang AE, Rees RS (1993) Cutaneous neoplasms. In: Greenfield U, Mulholland MW, Oldham KT, Zelenock GB (eds) Surgery: scientific principles and practice. Lippincott, Philadelphia, pp 2019-2035
28. Hölzle E, Kind P, Plewig G (1991) Pigmentierte Hautverän derungen: Klinik - Histopathologie - Differentialdiagnosen. Schattauer, Stuttgart, pp 1-128
29. Cumberlin R, de Moss E, Lassus M, Friedman M (1985) Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 3:1022-1032
30. Ghussen F, Krüger I, Groth W, Stützer H (1986) Randomisierte Melanomstudie zur Extremitätenperfusion. Behandlungsergebnisse 2 1/2 Jahre nach vorzeitigem Abbruch. Chirurg 57:619-624
31. Janoff KA, Moseson D, Nohlgren J, Davenport C, Richards C, Fletcher WS (1982) The treatment of stage I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg 196:316-323
32. Krementz ET (1986) Regional perfusion. Current sophistication, what next? Cancer 57:416-419
33. Martijn H, Oldhoff J, Schraffordt Koops H (1981) Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs. Europ J Cancer 17:471-479
34. Nagel K, Junginger T (1987) Extremitätenperfusion beim malignen Melanom. DMW 112:1626-1629
35. Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorski VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Mechl Z, Morabito A, Rodé I, Sergeev S, van Slooten E, Szczygiel K, Trapeznikov NN, Wagner RI (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420-2430
36. Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P (1990) Verbesserte intraoperative Leckkontrolle bei der isolierten Zytostatikaperfusion von Extremitätentumoren. Langenbecks Arch 375:208-213
37. Krauss J, Lange U, Pauer HD, Krauss I (1984) Farbstoffkonzentrationsmessungen zur Abstrombestimmung während und nach der zytostatischen Perfusion zur Behandlung von Extremitätentumoren. Z Exp Chir Transplant Künstl Organe 17:269-274
38. Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, Hart AA (1994) Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery 115:39-45
39. Bryant PJ, Balderson GA, Mead P, Egerton WS (1995) Hyperthermic isolated limb perfusion for malignant melanoma: response and survival. World J Surg 19:363-368
40. Clark WH Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 29:705-711